Τετάρτη 8 Φεβρουαρίου 2017

New assay shows promise to advance personalised therapy for cancer patients

One of the most promising areas of cancer research is personalised therapy using precision medicine. The National Cancer Institute's NCI-MATCH (Molecular Analysis for Therapy Choice) is a large, ongoing clinical trial that matches tumours to therapies...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2kGJPYy
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις